Tom Beckitt is the COO at Genea Biomedx and has over 15 years’ experience and success in the pharmaceutical and medical device industries covering drug and vaccine development, pharmacology and assisted reproductive technologies. Tom holds a Bachelor of Science in Biochemistry, an Honours in Organic Chemistry and a Post-Graduate Certificate in Clinical Trials.

Dr Robert Woolcott is one of Australia’s most experienced fertility specialists having practiced Fertility based medicine for over 25 years, performing over 10,000 IVF procedures and being the author of numerous peer-reviewed journal articles. In addition to this role, he is also a Director for Genea.

Bekezela Ngwenya has over 15 years of experience in quality assurance in the pharmaceutical and medical devices industries. She has a proven track record in establishing and maintaining quality management systems and is experienced in ensuring compliance with local and international standards. She is responsible for ensuring the quality and compliance of products manufactured by Genea Biomedx. Bekezela holds a Bachelor of Science in Applied Chemistry and a Masters of Business and Technology.

Teija Peura’s background is in basic research of advanced reproductive and biotechnology sciences in academia and private industry both in her native Finland and in Australia in Melbourne, Adelaide, Brisbane and Sydney. After two post-doctoral research roles she joined Sydney IVF/Genea initially in 2003 and again in 2010, where her role has progressed from stem cell research to medical device product development, and from exploration of new product opportunities to IP management and clinical expert regulatory support. She is currently focussed on management of new business development opportunities for Genea Biomedx at a global level. Teija holds a MSc and PhD in Biotechnology.